Le Lézard
Classified in: Health, Business
Subjects: LEG, POL, AVO

AAOS to Congress: Protect Healthcare Services Before Years End


Passing two crucial bills will provide physicians financial stability and timely access for patients

WASHINGTON, Nov. 15, 2022 /PRNewswire/ -- The American Association of Orthopaedic Surgeons (AAOS) is urging Congress to mitigate impending Medicare physician pay cuts and reform flawed prior authorization processes in year-end legislation. In a letter sent to congressional leaders on November 15, the AAOS asked Congress to pass the Supporting Medicare Providers Act of 2022 (H.R. 8800) which is nearing 100 cosponsors and the Improving Seniors' Timely Access to Care Act (H.R. 3173/S. 3018) which has already passed the U.S. House of Representatives.

Specifically, H.R. 8800 would prevent an impending 4.47% cut to the Medicare Physician Fee Schedule Conversation Factor in 2023. The scheduled cut is further exasperated by another 4% cut, totaling an approximately 8.5% payment reduction for the entire healthcare clinician community.

In the letter, AAOS noted that the impact of the cuts is compounded by the fact that physicians are the only group in the Medicare payment system whose reimbursement is not adjusted for inflation. When adjusting for increasing practice costs, Medicare physician reimbursement has actually dropped by 20% over the past two decades.

"These impending cuts and lack of inflationary update are simply not sustainable and continue to generate significant instability for physicians moving forward, threatening beneficiaries' timely access to essential health care services," wrote AAOS President Felix H. Savoie III, MD, FAAOS. He explained that without congressional action, the cuts will drive hospital consolidation, limit patient access, and harm physicians' ability to run their businesses.

The second bill, H.R. 3173/S. 3018, is supported by more than 500 organizations and seeks to improve prior authorization processes within Medicare Advantage. "While the prior authorization process is ostensibly intended to control costs, it can delay necessary medical care and negatively influence patient outcomes, consequentially creating a larger cost burden," wrote Dr. Savoie.

The AAOS letter to Congress cited two evidential studies to support its stance. One was from the Office of Inspector General at the U.S. Department of Health and Human Services that found Medicare Advantage plans inappropriately denied up to 85,000 requests in 2019. Another from the American Medical Association found 34% of physicians reported a serious adverse event for a patient due to prior authorization delays and spend an average of two days a week completing requests.

"Our patients and physicians cannot wait until the next Congress for additional action," said Dr. Savoie, noting that legislation passed by voice vote in October.

Read the full letter here.

About the AAOS

The American Association of Orthopaedic Surgeons (AAOS) Office of Government Relations promotes and advocates the viewpoint of the orthopaedic community before federal and state legislative, regulatory, and executive agencies. Based in Washington, DC, with additional staff in the Academy's headquarters in Rosemont, Illinois, the Office of Government Relations identifies, analyzes, and directs all health policy activities and initiatives to position the AAOS as the trusted leaders in advancing musculoskeletal health.

For more information on all AAOS advocacy efforts, visit http://www.aaos.org/dc.

SOURCE American Association of Orthopaedic Surgeons


These press releases may also interest you

at 12:36
Kedrion Biopharma Inc., an international biopharmaceutical company specializing in the research and development, production, and commercialization of plasma-derived therapeutic products used in treating rare and serious diseases, announced today that...

at 12:28
PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, today announced it was selected by X4 Pharmaceuticals, Inc. for the distribution of XOLREMDItm (mavorixafor), recently approved by the U.S....

at 12:20
Soleo Health, a national provider of complex specialty pharmacy services, announced today the opening of its latest pharmacy and ambulatory infusion center (AIC) in Ridgeland, Mississippi. Soleo Health Jackson offers a broad range of specialty...

at 12:08
Prices have gone up?and stayed up?since the pandemic, but Eyemart Express has bucked this consumer pricing trend by keeping its prescription eyewear affordable. Since its founding in 1990, the national optical retailer has remained committed to...

at 12:05
Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516) (Paris:POXEL), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic...

at 12:05
Pharmaceutical Strategies Group ("PSG"), an EPIC company, released its annual Trends in Specialty Drug Benefits Report, co-sponsored by Genentech, a member of the Roche Group, detailing the complexities of specialty drug access and affordability. The...



News published on and distributed by: